Variant report
Variant | esv3318660 |
---|---|
Chromosome Location | chr19:56713350-56722152 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:63)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BRCA1 | chr19:56720561-56720808 | Hela-S3 | cervix: | n/a | n/a |
2 | CEBPB | chr19:56720517-56720847 | Hela-S3 | cervix: | n/a | n/a |
3 | CEBPB | chr19:56716430-56716674 | HepG2 | liver: | n/a | chr19:56716533-56716544 |
4 | CEBPB | chr19:56716429-56716798 | A549 | lung: | n/a | chr19:56716763-56716774 chr19:56716533-56716544 chr19:56716763-56716774 chr19:56716761-56716774 chr19:56716761-56716774 |
5 | CEBPB | chr19:56716455-56716760 | IMR90 | lung: | n/a | chr19:56716533-56716544 |
6 | CEBPB | chr19:56716360-56717024 | Hela-S3 | cervix: | n/a | chr19:56716763-56716774 chr19:56716533-56716544 chr19:56716763-56716774 chr19:56716761-56716774 chr19:56716761-56716774 |
7 | CEBPB | chr19:56716510-56716908 | K562 | blood: | n/a | chr19:56716763-56716774 chr19:56716533-56716544 chr19:56716763-56716774 chr19:56716761-56716774 chr19:56716761-56716774 |
8 | CHD2 | chr19:56720635-56720730 | Hela-S3 | cervix: | n/a | n/a |
9 | CHD2 | chr19:56720040-56720297 | K562 | blood: | n/a | n/a |
10 | CTCF | chr19:56718992-56719287 | K562 | blood: | n/a | n/a |
11 | CTCF | chr19:56717496-56717536 | Lung_OC | lung: | n/a | n/a |
12 | CTCF | chr19:56719050-56719211 | LNCaP | prostate: | n/a | n/a |
13 | CTCF | chr19:56719180-56719330 | HEK293 | kidney: | n/a | n/a |
14 | CTCF | chr19:56718648-56718688 | GM20000 | blood: | n/a | n/a |
15 | CTCF | chr19:56719180-56719330 | HepG2 | liver: | n/a | n/a |
16 | CTCF | chr19:56719139-56719185 | Hela-S3 | cervix: | n/a | n/a |
17 | CTCF | chr19:56717973-56718013 | Spleen_OC | spleen: | n/a | n/a |
18 | CTCF | chr19:56719125-56719164 | NHEK | skin: | n/a | n/a |
19 | CTCF | chr19:56719019-56719288 | H1-hESC | embryonic stem cell: | n/a | n/a |
20 | CTCF | chr19:56719180-56719330 | HFF-Myc | foreskin: | n/a | n/a |
21 | CTCF | chr19:56718336-56718366 | GM13977 | blood: | n/a | n/a |
22 | CTCF | chr19:56719136-56719206 | MCF-7 | breast: | n/a | n/a |
23 | CTCF | chr19:56719082-56719218 | MCF-7 | breast: | n/a | n/a |
24 | CTCF | chr19:56719033-56719288 | K562 | blood: | n/a | n/a |
25 | CTCF | chr19:56720338-56720341 | HepG2 | liver: | n/a | n/a |
26 | CTCF | chr19:56717450-56717530 | GM10248 | blood: | n/a | n/a |
27 | CTCF | chr19:56719060-56719210 | K562 | blood: | n/a | n/a |
28 | CTCF | chr19:56719078-56719262 | GM12891 | blood: | n/a | n/a |
29 | CTCF | chr19:56718991-56719322 | K562 | blood: | n/a | n/a |
30 | CTCF | chr19:56719099-56719220 | HepG2 | liver: | n/a | n/a |
31 | CTCF | chr19:56719090-56719220 | ProgFib | skin: | n/a | n/a |
32 | CTCF | chr19:56719073-56719254 | K562 | blood: | n/a | n/a |
33 | CTCF | chr19:56719220-56719370 | K562 | blood: | n/a | n/a |
34 | CTCF | chr19:56719090-56719183 | GM13977 | blood: | n/a | n/a |
35 | CTCF | chr19:56719077-56719196 | GM19239 | blood: | n/a | n/a |
36 | CTCF | chr19:56719180-56719330 | GM12864 | blood: | n/a | n/a |
37 | CTCF | chr19:56715762-56715839 | Pancreas_OC | pancreas: | n/a | n/a |
38 | CTCF | chr19:56719096-56719240 | Gliobla | brain: | n/a | n/a |
39 | CTCF | chr19:56719082-56719234 | MCF-7 | breast: | n/a | n/a |
40 | CTCF | chr19:56719076-56719210 | GM10248 | blood: | n/a | n/a |
41 | CTCF | chr19:56719079-56719185 | GM12878 | blood: | n/a | n/a |
42 | CTCF | chr19:56720375-56720428 | K562 | blood: | n/a | n/a |
43 | CTCF | chr19:56719092-56719277 | Fibrobl | skin: | n/a | n/a |
44 | CTCF | chr19:56719115-56719186 | GM12892 | blood: | n/a | n/a |
45 | CTCF | chr19:56715929-56716008 | Kidney_OC | kidney: | n/a | n/a |
46 | CTCF | chr19:56719091-56719182 | Medullo | brain: | n/a | n/a |
47 | CTCF | chr19:56718988-56719220 | K562 | blood: | n/a | n/a |
48 | CTCF | chr19:56719041-56719244 | H1-hESC | embryonic stem cell: | n/a | n/a |
49 | CTCF | chr19:56717462-56717501 | LNCaP | prostate: | n/a | n/a |
50 | CTCF | chr19:56720342-56720426 | HepG2 | liver: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:56717707..56719210-chr19:56732793..56735030,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ZSCAN5B | TF binding region |
ZSCAN5C | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs531068512 | chr19:56714450-56714451 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs550690073 | chr19:56714468-56714469 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs536392714 | chr19:56715768-56715769 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs546617887 | chr19:56715807-56715808 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs566480732 | chr19:56715819-56715820 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs181501166 | chr19:56715830-56715831 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs186466761 | chr19:56715931-56715932 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs560068580 | chr19:56715965-56715966 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs190847411 | chr19:56715974-56715975 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs566442570 | chr19:56716360-56716361 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs144518410 | chr19:56716393-56716394 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs12984780 | chr19:56716395-56716396 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs535351948 | chr19:56716413-56716414 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs117424106 | chr19:56716458-56716459 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs538194692 | chr19:56716467-56716468 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs555142032 | chr19:56716521-56716522 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs184041575 | chr19:56716527-56716528 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs533987858 | chr19:56716529-56716530 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs553863558 | chr19:56716561-56716562 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs12709954 | chr19:56716579-56716580 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
21 | rs113166193 | chr19:56716653-56716654 | Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs534693551 | chr19:56716675-56716676 | Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs186119083 | chr19:56716707-56716708 | Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs532031109 | chr19:56716715-56716716 | Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs544185616 | chr19:56716728-56716729 | Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs561026522 | chr19:56716739-56716740 | Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs529932818 | chr19:56716786-56716787 | Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs540305088 | chr19:56716804-56716805 | Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs560265942 | chr19:56716844-56716845 | Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs190939782 | chr19:56716852-56716853 | Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs552139323 | chr19:56716903-56716904 | Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs73065794 | chr19:56716921-56716922 | Bivalent Enhancer | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs12232868 | chr19:56716982-56716983 | Bivalent Enhancer | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs551830297 | chr19:56717021-56717022 | Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs548610547 | chr19:56717027-56717028 | Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs568280278 | chr19:56717028-56717029 | Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs147316078 | chr19:56717053-56717054 | Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs79352363 | chr19:56717078-56717079 | Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs141046714 | chr19:56717085-56717086 | Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs539595056 | chr19:56717130-56717131 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
41 | rs556476651 | chr19:56717187-56717188 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
42 | rs576370772 | chr19:56717188-56717189 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
43 | rs28712522 | chr19:56717194-56717195 | Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs554926568 | chr19:56717195-56717196 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Congenital nephrotic syndrome | 18421352 | CNVD |
Astrocytoma | 17934521 | CNVD |
Leukemia | 17361228 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
renal disease | 20603712 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Bladder cancer | 21909424 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Wilms tumour | 21544195 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18852474 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Cervical cancer | 21062161 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Prostate cancer | 16573809 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Lung cancer | 18438408 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Heart disease | 21282601 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Breast cancer | 20409316 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:56716600-56717200 | Bivalent Enhancer | Hela-S3 | cervix |